Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients.
Buglione M, Alterio D, Maddalo M, Greco D, Gerardi MA, Tomasini D, Pegurri L, Augugliaro M, Marvaso G, Turturici I, Guerini A, Ansarin M, Spiazzi L, Costa L, Cossu Rocca M, Magrini SM, Jereczek-Fossa BA.
Buglione M, et al. Among authors: guerini a.
Radiat Oncol. 2021 Dec 20;16(1):239. doi: 10.1186/s13014-021-01966-4.
Radiat Oncol. 2021.
PMID: 34930353
Free PMC article.